SUMMIT European Cannabis Insights Summit 2026 — Exclusive industry intelligence Register Now
EVENT Cannabis Europa London 2026 — Europe's cannabis industry unites Get Tickets

Recent Searches

    New York’s new problem: what to do with a billion dollar weed mountain?

    By

    NEW YORK

    New York’s new problem: what to do with a billion dollar weed mountain?

    The Guardian reports that cannabis farms are booming upstate, but red tape is frustrating newly legal shops in the city, resulting in a “very big stash of cannabis”.

    The publication highlights that legalisation in New York has set off a cultivation boom that produced 300,000 pounds of cannabis in its first harvest. However, so far, New York has licensed far more farms than dispensaries, creating a glut of unsold product.

    This will likely be processed for its active ingredient or sold to edible-product producers, writes The Guardian.

    MEDICAL CANNABIS

    Dodgy science, poor access and high prices: the parallel medical world of medicinal marijuana in America

    Politico reports that after nearly three decades of medical cannabis use in California, patients are still facing a confusing patchwork of rules.

    It highlights that generally patients need a recommendation from one or two doctors to qualify for a medical cannabis card, however, patients who use medical cannabis in legal states do so almost entirely outside the traditional medical system because cannabis is still classified federally as a Schedule I drug on the Controlled Substances Act.

    This disconnect leads to problems for patients such as medical cannabis not being covered by health insurance — leaving some patients with bills of over $1,000 per month.

    “We’re denying patients the opportunity to try something that might or might not be useful for them … in a medically supervised way, where they might get relief,” said Julia Arnsten, chief of the Division of General Internal Medicine at Einstein-Montefiore College of Medicine in New York City and the founder of Montefiore’s medical cannabis center that sees over 3,000 patients.

    CANNABIS CANADA

    Indigenous cannabis entrepreneurs underrepresented in Canada, data suggests

    MJ Biz Daily has compiled new data showing that entrepreneurs in Indigenous communities are significantly underrepresented within Canada’s cultivation and retail cannabis industry.

    The data shows that:

    • Of the 755 cannabis corporations licensed by Canada’s federal government only six were located in an Indigenous community, or 0.8% of all licensees.
    • More than 3,300 provincially authorized recreational cannabis stores across the country, approximately 24 were situated on First Nations reserves at that time, or 0.7% of the retailers in Canada.

    The publication writes that the new data gives credence to claims by some Indigenous leaders that First Nations communities in Canada have been excluded from the economic opportunities and public health benefits stemming from the legalization and regulation of recreational cannabis.

    Darwin Douglas, CEO of All Nations told MJBizDaily: “We talk about reconciliation, but it hasn’t happened yet. There was an opportunity with the cannabis legislation.

    “The opportunity was to engage Indigenous people and nations, and consult with them on the legalization process, and understand how legalization and the building of this emerging cannabis industry was going to apply to Indigenous people.”

    CANNABIS EUROPA

    Position your brand in front of a European cannabis industry audience

    We are now accepting final applications for exhibitors at Cannabis Europa, and we want to invite your company to secure your place. This is your chance to showcase your products, services, and expertise to thousands of industry professionals from across Europe and beyond.

    As an exhibitor, you’ll have access to a captive audience of decision-makers and influencers, providing you with a unique opportunity to build relationships and generate new business. With over 1500 attendees expected to attend the event, you’ll have the opportunity to showcase your latest products and services and connect with industry leaders, investors, and innovators.

    By exhibiting at Cannabis Europa London 2023, you’ll benefit from:

    • Exposure to a targeted audience of industry professionals
    • Opportunities to connect with potential investors and partners
    • Increased visibility through extensive marketing campaigns
    • Access to exclusive networking events and opportunities
    • A platform to showcase your latest products and services

    We believe that your company would be a great addition to our exhibitor lineup, and we encourage you to apply for a space at the event as soon as possible.

    Ben Stevens

    Ben is the editor of Business of Cannabis. Since 2021, he has researched, written, and published the vast majority of the outlet’s content, delivering agenda-setting journalism on regulation, business strategy, and policy across Europe.

    The Briefing / Newsletter

    Insights
    you don't want
    to miss.

    A comprehensive, thoughtfully curated overview of the stories defining today's cannabis sector — breaking news, investigative features, expert commentary, and context-rich analysis to help you navigate events with clarity and confidence.

    • Policy & regulation
    • Markets & deals
    • Clinical & science
    Subscribe free